SUMMARY Cholesterol embolism after left heart catheterisation by the femoral approach was diagnosed in seven men (mean age 59*6 years) out of a total of 4587 catheterisations. Diabetes was present in four patients, systemic hypertension in three, and signs of extensive atherosclerosis in six; five patients were taking anticoagulant drugs. Acute pain in the legs or abdomen occurred in six patients, two of whom had abdominal angina; renal failure was present in six patients, cutaneous manifestations in five, and a cholesterol embolus was seen in the retina in one. Six out' of six patients had an appreciable increase in the erythrocyte sedimentation rate and five out of five had eosinophilia within a week of catheterisation. Renal failure was progressive in five patients, one of whom required haemodialysis. Three patients required amputation of the toes because of gangrene. Four patients died within four and a half months of catheterisation from causes not directly related to cholesterol embolism. At necropsy cholesterol emboli were found in all four patients. Cholesterol embolism is a rare but serious complication of left heart catheterisation.
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Cholesterol embolism is not widely recognised as a complication of cardiac catheterisation' -and may be difficult to diagnose.69 We report the main findings in seven patients who suffered cholesterol embolism after left heart catheterisation.
Patients and methods
Between January 1978 and April 1982 cholesterol embolism after left heart catheterisation was diagnosed in seven men out of a total of 4587 cardiac catheterisations. Diagnosis was based on the typical clinical features of cholesterol embolism after exclusion of other causes, and in four patients was confirmed at necropsy. :Presented with general malaise caused by renal failure. §2 months after catheterisation from fatal myocardial infarction; at necropsy CE in kidneys.
½4 months after catheterisation postoperatively; at necropsy CE in kidneys, adrenal glands, and stomach.
A pronounced increase in the erythrocyte sedimen-malities. in two patients failed to show cholesterol tation rate and a slight increase in the white blood cell emboli. Muscle biopsy specimens were not taken. count with eosinophilia was a common laboratory Treatment with plasma expanders, heparin, or finding, which in all cases occurred within a week of adrenal steroids appeared to have no influence on the catheterisation (Table 2) . Renal failure was present in course of the disease. Lumbar sympathectomy persix patients. No period of oliguria occurred. In four formed in one patient failed to improve the ischaemic patients urine analysis showed slight proteinuria signs in the toes. The outcome of the disorder was (<0.5 g/l). Only a few granular casts and red blood poor: in all three patients acrocyanosis of toes led to cells in the urinary sediment were noted. Skin biopsy gangrene and amputation of the toes. Renal failure specimens taken from sites with visible skin abnor-was stable in one and progressive in five patients, necessitating haemodialysis in one. This resulted in a slight improvement in renal function, and after nine weeks dialysis was stopped. Dialysis was resumed six months later, however, because of uraemic pericarditis. Four of the seven patients died within 2-4½2 months after catheterisation from causes not directly related to cholesterol embolism: three patients had a fatal myocardial reinfarction and one died postoperatively after resection of a thoracic aortic aneurysm. In all four cases necropsy showed many cholesterol emboli in the kidneys (Figure) and in one of them in the adrenal glands and the stomach.
Discussion
Thromboembolism due to thrombogenesis on vascular catheter surfaces or guide wires'I 12 is a well known complication of cardiac catheterisation.' -Manipulation with a catheter or guide wire can also dislodge and spread particles containing cholesterol from the arterial wall. This complication-cholesterol or atheromatous embolism-is seldom reported in relation to cardiac catheterisation. Nevertheless, in a postmortem study of patients with atherosclerosis who died within six months of left heart catheterisation Ramirez et al detected cholesterol embolism in 25-5% of necropsy specimens. 13 In an age and disease matched control group not undergoing catheterisation the incidence was only 4*3%. How often cholesterol emboli can occur without clinical symptoms is unknown.
Our findings confirm that extensive atherosclerosis, systemic hypertension, diabetes mellitus, and possibly anticoagulant treatment itself represent risk factors for the disease.7 [14] [15] [16] The fact that we routinely use a straight guide wire for all our catheterisations and that many of our patients are receiving long term anticoagulant treatment may partly explain the relatively high incidence of cholesterol emboli in our series of catheterisations.
Cholesterol emboli can spread to almost any organ and cause a diverse clinical picture, thereby making diagnosis dffficult.17-27 Cholesterol emboli should, however, be considered when acute pain, skin abnormalities, or renal failure occur after left heart catheterisation. An increase in the erythrocyte sedimentation rate and eosinophilia support the diagnosis, which becomes more definite when cholesterol emboli are found at ophthalmoscopy and in skin, bone marrow, or random muscle biopsy specimens.6 28 29 The outcome of cholesterol embolism is poor; peripheral ischaemic changes often lead to gangrene and amputation, and renal failure is progressive. Until now no therapeutic measures have proved effective: adrenal steroids, aspirin, dipyridamole, low molecular dextran, and lumbar sympathectomy have been used by us and others without improvement in symptoms or signs.23 30 The role of anticoagulants is controversial'63'; they may cause atherosclerotic plaque haemorrhage or prevent formation of the fibrin layer on top of the already ruptured plaque and thus increase the occurrence of cholesterol emboli. On the other hand, peripheral symptoms of ischaemia have disappeared after treatment with heparin possibly because of a decrease in superimposed thromboses. Nevertheless, symptoms were neither alleviated nor aggravated after heparin was given to one of our patients. If a definite source of the cholesterol emboli is identified-for instance an aortic aneurysm-the surgical removal of that source should be considered.30 32 We conclude that cholesterol embolism is a rare but serious complication of left heart catheterisation. Although no adequate treatment is yet known, early recognition of cholesterol emboli may at least make laborious diagnostic studies unnecessary. 
